SiriusPoint Ltd. (SPNT) Stock Price & How to Invest

Last updated November 2026

Short answer

SPNT is SiriusPoint Ltd., a Bermuda-domiciled global specialty insurer and reinsurer whose common shares trade on the NYSE, so exposure comes from owning the stock directly or holding a small-cap financials or insurance fund that includes it. As of November 20, 2026 the shares closed near $26.74, up about 27% year to date and about 35% over one year, for a market value of roughly $3.1 billion. They are priced as a completed turnaround: a trailing multiple near 6.6, roughly 1.4 times book value, and an underwriting result that has been near or under a 91 combined ratio for several quarters running, including a 90.1 percent core combined ratio in the third quarter of 2026.

SPNT stock price

As of 2026-11-20, SiriusPoint Ltd. (SPNT) last closed at $26.40, up 29.4% over the past year. Over the past 52 weeks it has traded between $19.32 and $27.38.

SPNT last close
$26.40
1 day
+0.49%
1 month
+2.80%
1 year
+29.41%
52-week range
$19.32 to $27.38
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or SiriusPoint Ltd.'s investor relations page. Walnut is informational, not investment advice.

SPNT key stats

At $26.40 on November 20, 2026, SiriusPoint Ltd. (SPNT) has a market cap of $3.0B and a P/E of 6.5 on trailing earnings (9.6 on forward earnings).

Market cap
$3.0B
P/E (trailing)
6.5
P/E (forward)
9.6
EPS (trailing 12 months)
$4.07
Price to book
1.4
Beta
0.57

Market cap, P/E and yield are measured at the $26.40 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with SiriusPoint Ltd. (SPNT)?

The last two weeks for SiriusPoint Ltd., as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • SPNT closed at $26.40 on November 20, 2026, down 0.6% over the past five trading days (from $26.57).

SiriusPoint Ltd. filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

What does SiriusPoint Ltd. (SPNT) do?

SiriusPoint was formed in 2021 when Third Point Reinsurance merged with Sirius International Insurance Group, and it now writes roughly $3.8 billion of gross premium a year across two segments, Insurance & Services and Reinsurance. The book spans about ten lines of business from four underwriting hubs, with accident and health the largest at roughly 27 percent of premium and general liability next at about 21 percent, and no other line above 10 percent. Alongside the underwriting operation sits International Medical Group, a travel and medical MGA that has been adding capability through bolt-on deals including Assist America in late 2025 and the World Nomads brand in early 2026. Headquarters are in Bermuda, staff numbers roughly 1,000, and the NYSE listing is the company's primary and only US listing.

For investors the picture is a repositioning that has largely already happened. Under CEO Scott Egan the company sold or ran off the volatile pieces, repurchased the entire $733 million stake held by former anchor shareholder CM Bermuda in February 2025, exited its 49 percent holding in Arcadian Risk Capital for about $140 million in January 2026, and steered new premium toward specialty insurance while deliberately letting reinsurance premium shrink. Second-quarter 2026 brought a 91.4 percent core combined ratio, a 13.8 percent operating return on equity, and the 21st consecutive quarter of favorable prior-year reserve development. Third-quarter 2026 brought a 90.1 percent core combined ratio, a 17.6 percent annualized operating return on equity, and operating earnings of $0.88 per share (GAAP $0.74 per diluted share) against a consensus near $0.64, with book value per diluted share excluding AOCI up 4 percent in the quarter to $20.21. Alongside those results the company announced a loss portfolio transfer to RiverStone covering substantially all of its remaining run-off reserves, which is subject to regulatory approval and is expected to unlock more than $200 million of capital and close out the legacy book. At about $26.74 per share on November 20, 2026, against that $20.21 of book value per diluted share excluding AOCI at September 30, the market is paying a modest premium to book for a business targeting a 12 to 15 percent operating return across the cycle, with the debate centered on whether that return holds as property and casualty pricing softens. Second-quarter earnings per share of about $0.67 came in slightly ahead of the roughly $0.64 consensus, although the shares fell about 9% in the days after that report before recovering; the third-quarter beat made five straight quarters at or above estimates. In November 2026 the company added John Sauerland to its board. In September 2026 RBC Capital Markets began coverage at outperform with a $30 price target, citing further book value growth and buybacks, and the company named Rachel Winoski chief human resources officer.

What's driving SiriusPoint Ltd. (SPNT)?

1. Specialty insurance replacing reinsurance in the mix

Insurance & Services gross written premium rose about 15 percent year over year to roughly $645 million in the second quarter of 2026, while Reinsurance premium fell about 9 percent to roughly $337 million. The trend continued in the third quarter, when Insurance & Services premium rose about 19.8 percent to roughly $673 million and Reinsurance edged up about 2.6 percent to roughly $318 million, leaving reinsurance down about 5.8 percent for the first nine months. Management describes the reinsurance decline as a choice rather than a loss of business, stepping back from property catastrophe and casualty treaties where terms have deteriorated. Accident and health, surety, and program business are where the incremental capital is going, and those lines carry lower loss volatility than the catastrophe book that once dominated the platform.

2. Underwriting margin, not premium growth

The core combined ratio came in at 91.4 percent for the second quarter and 90.1 percent for the first half, an improvement of roughly 2.3 points against the prior-year half, and 90.1 percent again in the third quarter. Reserve strength has also held up, with 21 straight quarters of favorable prior-year development at a company whose legacy Sirius and Third Point Re books were once a source of adverse charges, and the third quarter added about $18.3 million of favorable development in Insurance & Services. The planned loss portfolio transfer of the remaining run-off reserves to RiverStone would take most of that legacy exposure off the balance sheet. Whether that discipline survives a softening rate environment is the single variable most directly tied to the earnings power the stock is being valued on.

3. Capital returned through buybacks rather than dividends

SiriusPoint pays no common dividend and instead retires stock, returning roughly $295 million to shareholders in the first half of 2026 including about $51 million of open-market repurchases in the second quarter. The $733 million repurchase of the CM Bermuda position in February 2025 removed the overhang of a shareholder whose parent had entered receivership, and the share count has been falling since. Reported liquidity of roughly $1.1 billion and a Bermuda solvency ratio near 239 percent give the balance sheet room to keep doing it, and the RiverStone loss portfolio transfer, if approved, is expected to release more than $200 million of capital that had been supporting run-off reserves.

4. Fee income from the IMG services platform

International Medical Group sells travel medical and international health coverage and earns commission and service revenue that is not tied to SiriusPoint's own risk capital. Assist America closed in December 2025 and the World Nomads brand was agreed with nib Travel in February 2026, both of which widen the distribution and assistance side of that business. Fee-based earnings carry a different multiple from underwriting profit, and building more of them is one of the few ways a Bermuda carrier can meaningfully change how the market values it.

What are the risks to SiriusPoint Ltd. (SPNT)?

Catastrophe and large-loss exposure has not disappeared, and a single heavy wind or wildfire season can erase a year of underwriting margin at a company of this size. Reserve development is the second exposure: the current streak of favorable releases is a strength today and a comparison problem later, since a company cannot release reserves indefinitely. Pricing across property catastrophe and much of casualty reinsurance has been drifting lower, which is precisely why premium is falling in that segment, and a longer soft market would pressure the 12 to 15 percent operating return target. Ownership is concentrated enough to matter, with entities associated with Daniel Loeb holding roughly 9.5 percent, and take-private speculation has circulated around the name before without a transaction ever being signed. The share price itself has moved: at about $26.74 on November 20, 2026 the stock sits near the top of its 52-week range of roughly $19.15 to $27.55, so less of the turnaround is left unpriced than a year ago. Analysts expect fourth-quarter EPS of about $0.58, down about 17% year over year, and 2027 EPS of about $2.74, slightly below 2026's expected $2.82. The RiverStone loss portfolio transfer still needs regulatory approval, and the capital it frees has not yet been allocated. Finally, the trailing headline earnings multiple near 6.6 times is flattered by non-recurring items including asset sales, so anyone anchoring on it is looking at a number the operating business does not repeat.

What is the SiriusPoint Ltd. (SPNT) forecast?

4 analysts publish price targets on SPNT, averaging $30.25 as of November 2026, or +14.6% against the $26.40 share price on November 20, 2026. The published targets run from $27.00 to $32.00, a narrow spread, and the ratings split 2 buy, 2 hold, 0 sell. Over the last six months there have been 0 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full SPNT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is SPNT a buy or a sell?

We give no verdict on SiriusPoint Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Specialty insurance replacing reinsurance in the mix. Insurance & Services gross written premium rose about 15 percent year over year to roughly $645 million in the second quarter of 2026, while Reinsurance premium fell about 9 percent to roughly $337 million. The most optimistic published target, $32.00, assumes this works close to its best case.

The case against. Catastrophe and large-loss exposure has not disappeared, and a single heavy wind or wildfire season can erase a year of underwriting margin at a company of this size. The most pessimistic target, $27.00, is roughly what SPNT is worth if this bites instead.

Read the full bull and bear case on SPNT, including what would have to change to break either one. Walnut is not an investment adviser.

Has SiriusPoint Ltd. (SPNT) split its stock?

No. SiriusPoint Ltd. (SPNT) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is SiriusPoint Ltd. (SPNT) valued?

Market cap, P/E and dividend yield at today's price are in the SPNT key stats above. The business figures below come from SiriusPoint Ltd.'s reported results as of November 2026 and change when it next reports.

  • Core gross premiums written (Q3 2026): ~$991M, up ~13.7% YoY
  • Revenue (TTM): ~$3.1B; Q3 2026 revenue ~$868M, up ~16.5% YoY
  • Net income (TTM): ~$495M (includes non-recurring gains); Q3 2026 operating EPS $0.88 vs ~$0.64 expected
  • Core combined ratio (Q3 2026): ~90.1%
  • Book value per diluted share, ex-AOCI: ~$20.21 (September 30, 2026), up 4% in the quarter
  • Operating return on equity (Q3 2026, annualized): ~17.6%

As of November 2026: At about $26.74 the shares change hands near 1.3 times book value per diluted share ex-AOCI (about 1.4 times on Yahoo Finance's reported book), a modest premium for a carrier earning a mid-to-high-teens operating return. The trailing price to earnings ratio of roughly 6.6 is not a clean read, because trailing net income of about $495 million includes gains that will not recur; the forward multiple sits near 9.8 on consensus 2027 EPS of about $2.74, after about $2.82 expected for 2026. For an insurer, growth in book value per share plus capital returned is generally the more informative measure, and book value ex-AOCI rose 4 percent in the third quarter alone. The four-analyst mean target is about $30.25.

Who competes with SiriusPoint Ltd. (SPNT)?

Bermuda specialty insurers and reinsurers

Everest Group, RenaissanceRe, Arch Capital, AXIS Capital, Hamilton Insurance Group and Greenlight Capital Re write from the same domicile against many of the same brokers and cedents. Everest and Arch are the scale benchmarks for diversified specialty execution, while Hamilton and Greenlight Re are closer to SiriusPoint in size and in the challenge of proving a durable underwriting margin to a skeptical market.

US excess and surplus lines and program carriers

Kinsale Capital, Skyward Specialty, Bowhead Specialty, James River and Global Indemnity compete for the specialty primary and program business that SiriusPoint's Insurance & Services segment is growing into. These names typically trade at higher multiples of book than the Bermuda reinsurers, which is part of the argument for SiriusPoint continuing to shift its premium mix in that direction.

Accident, health and travel insurance specialists

Assurant, Chubb's accident and health division, Zurich's Cover-More and AIG Travel compete with International Medical Group for travel medical, expatriate health and assistance business. Accident and health is SiriusPoint's largest single line at roughly 27 percent of premium, so competitive pressure here reaches further into results than the segment's size alone would suggest.

What stocks are similar to SiriusPoint Ltd. (SPNT)?

Other names that sit close to SPNT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in SiriusPoint Ltd. (SPNT)

There are three common ways to get SPNT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so SPNT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where SPNT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on SiriusPoint Ltd. (SPNT)

SiriusPoint is a small-cap specialty underwriter whose case rests on holding a combined ratio around 90 while book value per share compounds and the share count shrinks, not on any single quarter's premium line. The third-quarter report on November 5, 2026 kept that case intact, with a 90.1 percent core combined ratio, a 17.6 percent annualized operating return on equity, operating EPS of $0.88 against a roughly $0.64 consensus, and a loss portfolio transfer to RiverStone on substantially all remaining run-off reserves that management expects to free more than $200 million of capital. With the stock up about 35% over the past year and near its 52-week high, the next read arrives against a higher starting valuation than a year ago.

More on SiriusPoint Ltd. (SPNT)

Whether SPNT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is SPNT a buy or a sell?, and where the stock could go from here in the SPNT stock forecast.

For income investors, whether SPNT pays a dividend and how the payout looks is covered in does SPNT pay a dividend? And to weigh SPNT against a peer, read the full side-by-side comparisons: SPNT vs EG and SPNT vs RNR.

Wondering how SPNT fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about SiriusPoint Ltd.

Ask Walnut's AI anything about SPNT and see how it fits what you own.

FAQ

What does SiriusPoint actually do?

+

SiriusPoint underwrites specialty insurance and reinsurance from Bermuda, writing roughly $3.8 billion of gross premium a year across about ten lines including accident and health, general liability, surety, property and marine. Alongside the underwriting arm it owns International Medical Group, a travel and international health platform that earns fee and commission income.

Is SPNT listed on a US exchange?

+

Yes. SiriusPoint Ltd. common shares trade on the New York Stock Exchange under SPNT, and that is the company's primary listing. The company is incorporated in Bermuda and files full annual and quarterly reports with the SEC as a US domestic filer, so 10-K and 10-Q disclosure is available rather than the lighter foreign private issuer regime.

Does SPNT pay a dividend?

+

No common dividend is currently paid. Capital returns run through share repurchases instead, with roughly $295 million returned in the first half of 2026 and a $733 million buyback of the CM Bermuda stake completed in February 2025. Investors looking for income from Bermuda carriers generally look at RenaissanceRe, Arch or Everest, all of which do pay one.

Why does SPNT trade at such a low price to earnings ratio?

+

Trailing net income of about $495 million includes non-recurring gains, notably from asset disposals such as the Arcadian Risk Capital sale, which pushes the trailing multiple down to roughly 6.6 at the November 20, 2026 price near $26.74. On forward estimates the multiple is about 9.8. Bermuda reinsurers also carry structurally lower multiples than primary specialty carriers because catastrophe exposure makes earnings lumpier.

What is a combined ratio and why does it matter for SPNT?

+

The combined ratio adds claims and expenses together as a percentage of premium earned, so anything under 100 means the underwriting itself made money before investment income. SiriusPoint reported a 91.4 percent core combined ratio in the second quarter of 2026 and 90.1 percent for the first half, then 90.1 percent again in the third quarter. Sustaining that level through a softer pricing cycle is the central question for the shares.

Is Third Point still involved with SiriusPoint?

+

Only as a minority holder. The company began life as Third Point Reinsurance, and Daniel Loeb's entities held around 9.5 percent following the February 2025 CM Bermuda transaction and the associated secondary offering. Third Point no longer manages the bulk of the investment portfolio in the way it did before 2022, and there has been press speculation about a take-private in the past with no agreement ever signed.

How exposed is SiriusPoint to natural catastrophes?

+

Less than it once was, by design. Reinsurance gross written premium fell about 9 percent year over year in the second quarter of 2026 as management stepped back from property catastrophe and casualty treaties on weakening terms, and was down about 5.8 percent for the first nine months. Accident and health now leads the book at roughly 27 percent, a line with far lower correlation to hurricane and wildfire seasons, though meaningful catastrophe exposure remains.

What would change the story for SPNT?

+

Three things tend to move it: the combined ratio drifting above the low 90s, reserve development turning unfavorable after a long run of favorable quarters (21 straight through mid-2026), regulators blocking the planned RiverStone loss portfolio transfer, or the pace of buybacks slowing. On the upside, a continued shift toward fee income at International Medical Group and higher-multiple specialty primary business is the mechanism through which the shares would earn a larger premium to book value.

How did SiriusPoint do in its latest quarter?

+

In the third quarter of 2026, reported on November 5, SiriusPoint posted a 90.1 percent core combined ratio, a 17.6 percent annualized operating return on equity, and operating earnings of $0.88 per share against a consensus near $0.64 (GAAP net income to common shareholders was about $86.8 million, or $0.74 per diluted share). Revenue was about $868 million, up roughly 16.5 percent, and book value per diluted share ex-AOCI rose 4 percent to $20.21. The company also announced a loss portfolio transfer of its remaining run-off reserves to RiverStone.

How has SPNT stock performed in 2026?

+

As of November 20, 2026, SPNT closed near $26.74, up about 27% year to date and about 35% over one year, close to the top of its 52-week range of roughly $19.15 to $27.55. The shares dipped about 9% after the August earnings report before recovering, and rose about 12% over the three months to November 20. RBC began coverage at outperform with a $30 target in September.

What is the SiriusPoint loss portfolio transfer with RiverStone?

+

Announced with third-quarter 2026 results on November 5, it is an agreement to transfer substantially all of SiriusPoint's remaining run-off reserves to RiverStone, supported by significant limit and collateral. It is subject to regulatory approval. The company expects it to unlock more than $200 million of capital that currently supports the run-off portfolio and to close out the legacy book; the reserve amount transferred was not given in the release.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with SiriusPoint Ltd.'s investor relations page or your broker before making investment decisions.